The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and humanTyrosine hydroxylase activation in depolarized dopaminergic terminals--involvement of Ca2+-dependent phosphorylation.Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosisTransient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitorsCharacterization of PEA-15, a major substrate for protein kinase C in astrocytesEndothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitroThe role of intraneuronal 5-HT and of tryptophan hydroxylase activation in the control of 5-HT synthesis in rat brain slices incubated in K+-enriched mediumDifferential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brainAlpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiatesIrreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in miceImpact of 6-hydroxydopamine lesions and cocaine exposure on mu-opioid receptor expression and regulation of cholinergic transmission in the limbic-prefrontal territory of the rat dorsal striatumRole of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.Inhibition of protein synthesis in cortical neurons during exposure to hydrogen peroxide.
P50
Q24320135-71EFF6DB-5F85-4B0E-8B2C-C349BCD16CC3Q27863465-76E1EEC1-74CE-4C57-BF88-85D42EC06ADCQ28144782-6562C916-D598-4FC4-B6A7-86682FD14592Q28181027-8CDDB6FB-57D6-46B5-918A-ED6C5CFE8AFBQ28267041-448FD195-B197-4E80-9E70-F236A9DF6CF3Q28281048-D9C53B1A-6D3F-44AF-A9FF-6A509D7455A8Q28291623-0DE62A50-267A-47D7-9570-6D2F48E48099Q28508353-0D5858BB-72FB-4C57-96DB-CC54B5154BA9Q28510256-4579E36E-34E4-4C71-A3BB-9CB615DB8441Q28511827-002DFFC8-C9FE-46CC-812A-053290232947Q28573395-F256D89B-57BC-4425-994D-9E5B77BDA81EQ30965915-D689F90A-0EA9-4EAC-BAB6-2F317EB862A4Q31961962-13EEB79B-BD4E-4ABC-9987-7842F34C239C
P50
description
Frans apotheker
@nl
French pharmacist and professor
@en
name
Jacques Glowinski
@ast
Jacques Glowinski
@ca
Jacques Glowinski
@da
Jacques Glowinski
@en
Jacques Glowinski
@es
Jacques Glowinski
@fr
Jacques Glowinski
@hu
Jacques Glowinski
@nb
Jacques Glowinski
@nl
Jacques Glowinski
@nn
type
label
Jacques Glowinski
@ast
Jacques Glowinski
@ca
Jacques Glowinski
@da
Jacques Glowinski
@en
Jacques Glowinski
@es
Jacques Glowinski
@fr
Jacques Glowinski
@hu
Jacques Glowinski
@nb
Jacques Glowinski
@nl
Jacques Glowinski
@nn
prefLabel
Jacques Glowinski
@ast
Jacques Glowinski
@ca
Jacques Glowinski
@da
Jacques Glowinski
@en
Jacques Glowinski
@es
Jacques Glowinski
@fr
Jacques Glowinski
@hu
Jacques Glowinski
@nb
Jacques Glowinski
@nl
Jacques Glowinski
@nn
P166
P214
P227
P244
P268
P269
P1412
P1559
Jacques Glowinski
@fr
P166
P19
P21
P213
0000 0000 2652 8349
P214
P227
1130790703